Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 653

1.

Accuracy of international guidelines for identifying significant fibrosis in hepatitis B e antigen--negative patients with chronic hepatitis.

Sanai FM, Babatin MA, Bzeizi KI, Alsohaibani F, Al-Hamoudi W, Alsaad KO, Al Mana H, Handoo FA, Al-Ashgar H, Alghamdi H, Ibrahim A, Aljumah A, Alalwan A, Altraif IH, Al-Hussaini H, Myers RP, Abdo AA.

Clin Gastroenterol Hepatol. 2013 Nov;11(11):1493-1499.e2. doi: 10.1016/j.cgh.2013.05.038. Epub 2013 Jun 28.

PMID:
23811251
2.

Discriminant value of serum HBV DNA levels as predictors of liver fibrosis in chronic hepatitis B.

Sanai FM, Helmy A, Bzeizi KI, Babatin MA, Al-Qahtani A, Al-Ashgar HA, Al-Mdani AS, Al-Akwaa A, Almutharea S, Khan MQ, Alghamdi AS, Farah T, Al-Hamoudi W, Saadeh M, Abdo AA.

J Viral Hepat. 2011 Jul;18(7):e217-25. doi: 10.1111/j.1365-2893.2011.01437.x. Epub 2011 Mar 1.

PMID:
21692936
4.

Histologic evidence of active liver injury in chronic hepatitis B patients with normal range or minimally elevated alanine aminotransferase levels.

Hu KQ, Schiff ER, Kowdley KV, Min AD, Shiffman ML, Lee WM, Goodman ZD, Dau LO, Peschell KJ, Fagan EA, Flaherty JF.

J Clin Gastroenterol. 2010 Aug;44(7):510-6. doi: 10.1097/MCG.0b013e3181d34c65.

PMID:
20179614
5.

Decreasing hepatitis B viral load is associated with a risk of significant liver fibrosis in hepatitis B e antigen positive chronic hepatitis B.

Xie Q, Hu X, Zhang Y, Jiang X, Li X, Li J.

J Med Virol. 2014 Nov;86(11):1828-37. doi: 10.1002/jmv.24000. Epub 2014 Aug 21.

PMID:
25145769
6.

Clinical factors associated with liver stiffness in hepatitis B e antigen-positive chronic hepatitis B patients.

Wong GL, Wong VW, Choi PC, Chan AW, Chim AM, Yiu KK, Chan HY, Chan FK, Sung JJ, Chan HL.

Clin Gastroenterol Hepatol. 2009 Feb;7(2):227-33. doi: 10.1016/j.cgh.2008.10.023. Epub 2008 Oct 30.

PMID:
19121647
7.

Systematic review with meta-analysis: the proportion of chronic hepatitis B patients with normal alanine transaminase ≤ 40 IU/L and significant hepatic fibrosis.

Chao DT, Lim JK, Ayoub WS, Nguyen LH, Nguyen MH.

Aliment Pharmacol Ther. 2014 Feb;39(4):349-58. doi: 10.1111/apt.12590. Epub 2014 Jan 6. Review.

8.

HBV DNA level could predict significant liver fibrosis in HBeAg negative chronic hepatitis B patients with biopsy indication.

Praneenararat S, Chamroonkul N, Sripongpun P, Kanngurn S, Jarumanokul R, Piratvisuth T.

BMC Gastroenterol. 2014 Dec 19;14:218. doi: 10.1186/s12876-014-0218-6.

9.

Significant hepatic histopathology in chronic hepatitis B patients with serum ALT less than twice ULN and high HBV-DNA levels in Indonesia.

Lesmana CR, Gani RA, Hasan I, Simadibrata M, Sulaiman AS, Pakasi LS, Budihusodo U, Krisnuhoni E, Lesmana LA.

J Dig Dis. 2011 Dec;12(6):476-80. doi: 10.1111/j.1751-2980.2011.00540.x.

PMID:
22118698
10.

Off-therapy durability of response to entecavir therapy in hepatitis B e antigen-negative chronic hepatitis B patients.

Jeng WJ, Sheen IS, Chen YC, Hsu CW, Chien RN, Chu CM, Liaw YF.

Hepatology. 2013 Dec;58(6):1888-96. doi: 10.1002/hep.26549. Epub 2013 Oct 17.

PMID:
23744454
11.

[Accuracy of FibroScan for the diagnosis of liver fibrosis influenced by serum alanine aminotransferase levels in patients with chronic hepatitis B].

Chen XB, Zhu X, Chen LY, Chen EQ, Tang H.

Zhonghua Gan Zang Bing Za Zhi. 2011 Apr;19(4):286-90. doi: 10.3760/cma.j.issn.1007-3418.2011.04.013. Chinese.

PMID:
21586228
12.

A model to predict antiviral treatment in HBeAg negative chronic hepatitis B with alanine aminotransferase≤2 upper limit of normal.

Gao S, Fan YC, Zhao J, Sun FK, Han J, Zhao ZH, Wang K.

Liver Int. 2014 Aug;34(7):e229-37. doi: 10.1111/liv.12344. Epub 2013 Oct 23.

PMID:
24112455
13.

Evaluation of normal or minimally elevated alanine transaminase, age and DNA level in predicting liver histological changes in chronic hepatitis B.

Alam S, Ahmad N, Mustafa G, Shrestha A, Alam AK, Khan M.

Liver Int. 2011 Jul;31(6):824-30. doi: 10.1111/j.1478-3231.2011.02491.x. Epub 2011 Mar 6.

PMID:
21645213
14.

Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA.

Martinot-Peignoux M, Lapalus M, Laouénan C, Lada O, Netto-Cardoso AC, Boyer N, Ripault MP, Carvalho-Filho R, Asselah T, Marcellin P.

J Clin Virol. 2013 Oct;58(2):401-7. doi: 10.1016/j.jcv.2013.08.010. Epub 2013 Aug 16.

PMID:
24004660
15.

Liver fibrosis progression is uncommon in patients with inactive chronic hepatitis B: a prospective cohort study with paired transient elastography examination.

Wong GL, Chan HL, Yu Z, Chan HY, Tse CH, Wong VW.

J Gastroenterol Hepatol. 2013 Dec;28(12):1842-8. doi: 10.1111/jgh.12327.

PMID:
23829381
16.

Efficacy of entecavir in chronic hepatitis B patients with mildly elevated alanine aminotransferase and biopsy-proven histological damage.

Wu IC, Lai CL, Han SH, Han KH, Gordon SC, Chao YC, Tan CK, Sievert W, Tanwandee T, Xu D, Neo BL, Chang TT.

Hepatology. 2010 Apr;51(4):1185-9. doi: 10.1002/hep.23424.

PMID:
20044806
17.

[Characteristic of liver pathology in HBeAg-positive and HBeAg-negative chronic hepatitis B patients with mildly elevated ALT].

Liu SQ, Zhu XJ, Sun XH, Li M, Gao YQ.

Zhonghua Gan Zang Bing Za Zhi. 2012 May;20(5):348-52. doi: 10.3760/cma.j.issn.1007-3418.2012.05.009. Chinese.

PMID:
22971279
18.

A survey of chronic hepatitis B patient management practices in the European Union.

Berg T, Benhamou Y, Calleja JL, Levrero M, Johnson W, Ellis N.

J Viral Hepat. 2010 Sep;17(9):624-30. doi: 10.1111/j.1365-2893.2010.01318.x. Epub 2010 May 4.

PMID:
20487257
19.

Lower baseline ALT cut-off values and HBV DNA levels better differentiate HBeAg- chronic hepatitis B patients from inactive chronic carriers.

Assy N, Beniashvili Z, Djibre A, Nasser G, Grosovski M, Nseir W.

World J Gastroenterol. 2009 Jun 28;15(24):3025-31.

20.

Relationship between level of hepatitis B virus DNA and liver disease: a population-based study of hepatitis B e antigen-negative persons with hepatitis B.

McMahon BJ, Bulkow L, Simons B, Zhang Y, Negus S, Homan C, Spradling P, Teshale E, Lau D, Snowball M, Livingston SE.

Clin Gastroenterol Hepatol. 2014 Apr;12(4):701-6.e1-3. doi: 10.1016/j.cgh.2013.09.005. Epub 2013 Sep 11.

Supplemental Content

Support Center